The Cycle of Technology Panics: Examining the Repeated Concerns and Anxieties Surrounding Artificial Intelligence
Chat-GPT에 대한 고민| The One with Doc Ayomide: Episode 18 (2023)
When considering drug development, it’s a lifelong process with longitudinal studies. Establishing safety, efficacy, and relationship response is crucial. However, once the drug is out in the real world, continuous evidence gathering is necessary. The end users of the drug play a vital role in providing feedback on real-world experiences, highlighting factors like adherence and co-morbidities that may impact dosing. It becomes a partnership between end users and the drug development team. This should be the same with AI. The onus on gatekeeping should not be on the developers alone. Placing the responsibility solely on AI developers is fundamentally flawed. This raises significant concerns for me.” — Mo! (2023)
“The fear of job displacement is understandable with the automation…
